Development or exacerbation of hidradenitis suppurativa in two transgender men after initiation of testosterone therapy

Br J Dermatol. 2021 Jun;184(6):1192-1194. doi: 10.1111/bjd.19812. Epub 2021 Mar 9.

Authors

M Buonomo¹, M D Mansh², D Thorpe³, N Goldfarb^{2

4

5

6}

Affiliations

¹ University of Minnesota Medical School, Minneapolis, MN, USA.
² Department of Dermatology, University of Minnesota, MN, USA.
³ Department of Obstetrics and Gynecology, Park Nicollet Health Services, St Louis Park, MN, USA.
⁴ Department of Medicine, University of Minnesota, MN, USA.
⁵ Department of Medicine, Minneapolis VA Medical Center, MN, USA.
⁶ Department of Dermatology, Minneapolis VA Medical Center, MN, USA.

PMID: 33448331
DOI: 10.1111/bjd.19812

No abstract available

Publication types

Letter

MeSH terms

Hidradenitis Suppurativa* / chemically induced
Hidradenitis Suppurativa* / drug therapy
Humans
Male
Testosterone / adverse effects
Testosterone Congeners
Transgender Persons*

Substances

Testosterone Congeners
Testosterone